Food-Grade Exosome Production Services

OverviewServicesSamplesAdvantagesApplicationsFAQs

Overview

High-quality food-grade mEV ingredients begin with a production infrastructure engineered for compliance, not adapted to it. At Creative BioMart Microbe, our Food-Grade Exosome Production Services translate laboratory-scale mEV protocols into contaminant-controlled, food-ingredient-ready manufacturing under conditions that satisfy FDA 21 CFR, EFSA novel food guidance, and Codex Alimentarius frameworks for microbial-derived ingredients.

Every batch produced through this platform undergoes a multi-panel safety screen covering pathogen exclusion (Salmonella, Listeria monocytogenes, E. coli O157:H7, coagulase-positive Staphylococcus aureus), heavy metal quantification (Pb, Cd, As, Hg), allergen residue analysis, and endotoxin measurement. The production environment operates under documented sanitation protocols with validated cleaning verification, segregated raw material handling, and environmental monitoring—not merely an add-on QC check at the end, but an embedded quality system woven into every unit operation. Clients receive production batches supported by batch-specific Certificates of Analysis, safety testing reports, and regulatory documentation packages designed for GRAS self-affirmation dossiers or novel food submissions. Contact us to discuss your food-grade mEV production requirements.

Schematic overview of the food-grade microbial exosome production platform showing strain verification, contaminant-controlled fermentation, multi-panel safety testing, endotoxin and allergen control, and batch documentation release arranged along a vertical workflow with status indicators and connecting arrows.
Figure 1. Schematic overview of the food-grade exosome production platform, integrating food-safe strain verification, contaminant-controlled fermentation, multi-panel food-safety testing, endotoxin and allergen control, and batch documentation release into a comprehensive quality framework.

Services

Service Workflow

Our production workflow follows a contaminant-controlled, batch-documented pipeline that treats food safety as a process attribute rather than an endpoint test. Each stage—from incoming strain qualification through final batch release—is governed by predefined acceptance criteria, in-process monitoring checkpoints, and traceable documentation. The result is mEV preparations that are analytically characterized, safety-tested, and ready for integration into functional food products, nutraceutical formulations, or medical food development programs.

Horizontal process flowchart showing six steps of food-grade exosome production: Strain Qualification, Media Preparation, Contaminant-Controlled Fermentation, Harvest and Clarification, Multi-Panel Safety Testing, and Batch Release with Documentation.

Service Details

3D illustration of a transparent petri dish with microbial colonies beside a document with a gold certification seal and a DNA helix, representing strain qualification and regulatory verification.

Food-Safe Strain Sourcing & GRAS/QPS Regulatory Verification

We qualify production strains against food-grade regulatory frameworks through species-level identity confirmation, safety characterization, and regulatory status documentation. Our platform maintains a curated panel of GRAS-notified Bacillus subtilis strains and QPS-listed lactic acid bacteria and bifidobacteria ready for immediate deployment. Client-provided isolates undergo the same rigorous qualification pipeline with full traceability. The output is a regulatory-positioning dossier that maps each strain to applicable food safety frameworks and identifies any data gaps requiring resolution before production scale-up.

3D illustration of a stainless steel benchtop bioreactor with a digital control panel, surrounded by sterile tubing and media bottles in a clean production environment.

Contaminant-Controlled Fermentation & Production

We operate dedicated food-grade production suites with segregated material flow, validated cleaning and sanitization protocols, environmental monitoring programs, and personnel hygiene controls aligned with food manufacturing GMPs. Fermentation is conducted in closed-system bioreactors using food-grade media components with documented supplier qualification. Each production campaign is bracketed by pre- and post-campaign environmental swabbing and equipment rinse-water testing to verify sanitization effectiveness.

3D illustration of multiple test panels arranged on a laboratory bench showing pathogen screening plates, heavy metal analysis readout, and allergen test strips, with a document bearing checkmarks.

Multi-Panel Food-Safety Testing

Each production batch undergoes a comprehensive food-safety testing battery: pathogen screening for Salmonella spp., Listeria monocytogenes, E. coli O157:H7, and coagulase-positive Staphylococcus aureus; heavy metal quantification by ICP-MS for Pb, Cd, As, and Hg; allergen residue analysis covering milk, soy, gluten, and egg; and endotoxin measurement by LAL or recombinant factor C assay. Optional extended panels for mycotoxins and pesticide residues are available for clients pursuing specific market-access requirements.

3D illustration of a filtration and purification system showing a chromatography column with endotoxin removal, flanked by quality control readout displays showing pass/fail indicators.

Endotoxin & Allergen Control

Beyond detection, we implement active control strategies for endotoxin and allergen risk. Endotoxin reduction is achieved through validated purification steps including detergent-free phase separation and affinity depletion, with lot release testing confirming endotoxin levels within food-grade thresholds. Allergen control is managed through dedicated equipment segregation, validated allergen cleaning protocols, and raw material supplier allergen declarations. Clients targeting allergen-free labeling claims receive a comprehensive allergen risk assessment and supporting documentation.

3D illustration of a formal document with a teal cover, gold certification seal, and a QR-like code, accompanied by a vial of purified EVs and a green checkmark indicating batch approval.

Batch Documentation & Certificate of Analysis

Every production batch is released with a comprehensive documentation package: a batch-specific Certificate of Analysis summarizing all safety test results, physico-chemical characterization data, and acceptance criteria conformance; a production batch record documenting process parameters, in-process controls, and deviations; and a regulatory support dossier compiling strain qualification evidence, safety testing methodology, and compliance statements mapped to target-market food regulations. Documentation is formatted to support GRAS self-affirmation packages and novel food authorization submissions.

Service Specifications & QC Standards

iconProduction Environment & Infrastructure

Parameter Specification
Production Suites Dedicated food-grade segregated suites; no shared equipment with research-grade or pharmaceutical operations
Environmental Classification Controlled access; HEPA-filtered air supply; positive pressure maintenance; monitored temperature and humidity
Cleaning Validation CIP/SIP protocols; pre- and post-campaign environmental swabbing; equipment rinse-water testing
Material Flow Unidirectional segregated flow from raw material receipt through production to batch release
Personnel Controls Hygiene protocols, gowning requirements, and access logging aligned with food manufacturing practices

iconIn-Process Control Points

Control Stage Monitored Parameters Acceptance Criteria
Pre-production Environmental monitoring (air, surfaces, water); equipment qualification status All within established limits; equipment IQ/OQ/PQ current
Inoculum preparation Optical density, purity check, viability OD within target range; Gram stain pure; viability >90%
Fermentation mid-point pH, dissolved oxygen, optical density, temperature All within strain-specific SOP ranges
Harvest Culture purity, endotoxin level, optical density No contamination; endotoxin within food-grade threshold
Post-purification Particle concentration, size distribution, zeta potential, purity NTA and DLS within batch release specifications
Batch release Full safety panel, physico-chemical characterization, documentation completeness All acceptance criteria met; CoA issued

iconFood-Safety Testing Panel

Test Category Analytes / Targets Acceptance Criterion
Pathogen Screening Salmonella spp., Listeria monocytogenes, E. coli O157:H7, coagulase-positive Staphylococcus aureus Absent per batch
Heavy Metals Pb, Cd, As, Hg Reported; within food-grade regulatory limits
Allergen Residues Milk, Soy, Gluten, Egg Reported; < applicable threshold
Endotoxin LAL / recombinant factor C Reported per batch
Mycotoxins (optional) Aflatoxins B1/B2/G1/G2, Ochratoxin A, Zearalenone, Deoxynivalenol Reported; within regulatory limits
Pesticide Residues (optional) Multi-residue panel Reported; within regulatory limits

iconProduction Specifications

Parameter Specification
Eligible Strains GRAS Bacillus subtilis, GRAS/QPS-listed lactic acid bacteria, QPS-listed Bifidobacterium and Lactobacillus spp.
Production Scale Flexible batch production with scale-up pathway development
Vesicle Yield 1012 – 1015 particles per batch
Particle Size (NTA) 30 – 300 nm
Zeta Potential −10 to −40 mV (strain-dependent)
Production Environment Food-grade segregated suites; validated cleaning and sanitization
Media Components Food-grade; supplier-qualified; documented traceability
Process Monitoring Temperature, pH, dissolved oxygen, optical density; real-time recording

iconTurnaround Time

Project Type Timeline
Strain qualification and GRAS/QPS verification (existing strain) 2–3 weeks
Strain qualification (client-provided, new isolate) 4–6 weeks
Fermentation process transfer and adaptation 3–4 weeks
Single production batch (development scale) 3–4 weeks
Single production batch (pilot scale) 5–6 weeks
Multi-batch production campaign (3 batches) 8–12 weeks
Expedited timeline +50% fee, 40% time reduction

Timeline may vary based on strain complexity, production scale, and safety testing scope.

iconDeliverables

  • Strain qualification report: Species identity, safety profile, GRAS/QPS regulatory status, suitability assessment for food-grade production.
  • Production batch record: Process parameters, in-process control data, environmental monitoring results, deviation log.
  • Batch-specific Certificate of Analysis: Particle concentration, size distribution, zeta potential, purity metrics, pathogen screening, heavy metal quantification, endotoxin level, allergen residues.
  • Food-safety testing report: Full analytical data for all testing panels with method descriptions, detection limits, and acceptance criteria evaluation.
  • Regulatory support dossier: Strain qualification evidence, safety testing methodology, compliance statements, documentation formatted for GRAS self-affirmation or novel food submissions.
  • Retained samples: Archived retention samples from each batch for future reference testing.

iconQuality Control

  • Strain identity confirmed by 16S rRNA sequencing for every production campaign.
  • Pre-production environmental monitoring: Surface swabbing and air sampling in production suites.
  • In-process controls: Optical density, pH, dissolved oxygen, and contamination check at defined fermentation time points.
  • Post-production batch release testing: Full food-safety panel, NTA particle characterization, and purity verification on every batch.
  • Cleaning verification: Equipment rinse-water testing and surface swabbing between production campaigns.
  • Intra-batch CV for particle concentration: ≤15%.
  • Batch-to-batch consistency: CV <20% for yield and particle characteristics across campaigns.
  • All testing performed under documented SOPs with equipment calibration and analyst training records maintained.

Sample Requirements

Required Information Optional Information Not Accepted
  • Strain species, source, and isolation history
  • Existing GRAS notice or QPS status documentation (if available)
  • Target food product category and intended use level
  • Desired production scale and batch quantity
  • Target regulatory markets (FDA, EFSA, other)
  • Known allergen or sensitivity concerns related to production strain
  • Prior fermentation or safety testing data
  • Reference genome or whole-genome sequencing data
  • Desired particle concentration or total particle yield per batch
  • Specific documentation format requirements for regulatory submission
  • Preferred shipping container and storage condition
  • Timeline requirements for regulatory submission
  • Pathogenic or BSL-2/BSL-3 classified strains
  • Strains with undocumented origin, isolation history, or safety profile
  • Genetically modified organisms without proper containment documentation
  • Strains harboring transferable antibiotic resistance genes
  • Mixed or contaminated cultures
  • Samples shipped without cold-chain documentation

Recommended Starting Material by Service:

Service Minimum Recommended
Strain qualification (existing strain) Glycerol stock or lyophilized culture 1 mL glycerol stock (15% v/v glycerol)
Strain qualification (new isolate) Active culture on agar slant 1 mL glycerol stock + agar slant
Fermentation process transfer 1 qualified strain + protocol 3 qualified strains for parallel comparison
Single production batch (small scale) 500 mL – 1 L culture volume 2–5 L culture volume
Multi-batch production campaign 1 qualified strain 2–3 strains with comparative analysis

Storage & Shipping: Ship production strains as glycerol stocks on dry ice with cold-chain documentation. Provide strain origin, isolation history, prior characterization data, and any existing safety assessment reports. For client-provided strains, include a completed strain information form detailing species, source, and intended food application. Non-food-safe or pathogenic strains cannot be accepted for food-grade production under any circumstances.

Our Advantages

  • Segregated Food-Grade Infrastructure — Dedicated production suites with segregated material flow and validated cleaning prevent cross-contamination between food-grade and research-grade activities.
  • Validated Cleaning & Sanitization — CIP/SIP protocols verified by environmental swabbing and rinse-water testing ensure residual-free equipment turnover between production campaigns.
  • Real-Time Process Monitoring — Integrated PAT tracks temperature, pH, dissolved oxygen, and optical density in real time for immediate deviation detection and corrective action.
  • Supplier-Qualified Raw Materials — All raw materials and media components are supplier-qualified with documented traceability to meet food regulator and brand transparency demands.
  • Batch-to-Batch Consistency — Standardized SOPs and defined control points maintain intra-batch CV ≤15% and batch-to-batch CV <20% for reproducible quality attributes.
  • Scalable from Pilot to Commercial — Process development capabilities span from laboratory feasibility through pilot scale, with validated correlation studies supporting commercial manufacturing scale-up.

Applications

3D scene showing a pilot-scale bioreactor system with process analytical technology sensors, connected to sampling ports and inline monitoring displays, representing early-stage production feasibility studies.

Pilot-Scale Production for Feasibility Studies

Small-batch production campaigns to validate strain productivity, establish baseline safety profiles, and generate preliminary CoA data for investor or regulatory pre-submission meetings.

3D scene showing multiple production batches lined up with stability testing timelines, certificates of analysis, and consistency trend charts, representing multi-batch campaign programs.

Multi-Batch Campaigns for Stability Programs

Structured multi-batch production with inter-batch consistency monitoring to support shelf-life studies, process robustness validation, and regulatory dossier requirements for commercial authorization.

3D scene showing parallel bioreactors with different bacterial strains, each connected to comparative analytics dashboards displaying yield, particle size, and safety metrics side by side.

Strain Comparison & Selection Campaigns

Head-to-head production runs across multiple GRAS or QPS strains with standardized analytics to identify the optimal vesicle-producing candidate for a target application or regulatory pathway.

3D scene showing a technology transfer package with process protocols, analytical methods, and acceptance criteria documents being handed from pilot facility to commercial CMO manufacturing plant.

Technology Transfer to CMO Partners

Comprehensive tech-transfer packages including qualified production protocols, validated analytical methods, and acceptance criteria for seamless scale-up to commercial contract manufacturing organizations.

FAQs

Q: What distinguishes food-grade production from research-grade mEV preparation?

A: Food-grade production operates under documented food manufacturing practices with segregated suites, validated cleaning protocols, environmental monitoring, and supplier-qualified food-grade raw materials. Every batch undergoes the complete multi-panel food-safety testing battery—pathogens, heavy metals, allergens, and endotoxin. Research-grade preparation is conducted in standard laboratory conditions without these food-safety controls or release testing. The two are operationally and infrastructurally distinct, and research-grade material cannot be retrospectively “upgraded” to food-grade status.

Q: Which microbial strains are eligible for food-grade production?

A: Eligible strains include GRAS-notified Bacillus subtilis, QPS-listed lactic acid bacteria (Lactobacillus, Lactiplantibacillus, Limosilactobacillus, Levilactobacillus, Lactococcus, Streptococcus), QPS-listed Bifidobacterium spp., and other species with documented safe-use history in food. Strains harboring transferable antibiotic resistance genes, known virulence factors, or toxin production capability are excluded regardless of taxonomic classification. Custom strain qualification for client-provided isolates is available.

Q: What safety tests are performed on every production batch?

A: Every batch is tested for: (1) pathogen exclusion—Salmonella spp., Listeria monocytogenes, E. coli O157:H7, coagulase-positive Staphylococcus aureus; (2) heavy metals—Pb, Cd, As, Hg by ICP-MS; (3) allergen residues—milk, soy, gluten, egg by immunoassay; (4) endotoxin—by LAL or recombinant factor C assay. Extended optional panels for mycotoxins and pesticide residues are available. All results appear on the batch Certificate of Analysis.

Q: Do you accept client-provided strains for food-grade production?

A: Yes, subject to our strain qualification pipeline. Client-provided strains undergo species identity confirmation, safety profiling (antibiotic resistance, hemolytic activity, virulence factor screening, biogenic amine production), and regulatory status assessment. Strains must meet all food-grade safety criteria before production can commence. The qualification process typically takes 4–6 weeks. All client strains are handled under confidentiality agreements with secure strain banking.

Q: What is your equipment changeover protocol between production campaigns?

A: Between campaigns, equipment undergoes CIP/SIP cleaning cycles followed by rinse-water testing for residual media components and endotoxin. Surface swabbing with ATP bioluminescence monitoring verifies sanitization effectiveness. Environmental air sampling confirms suite cleanliness before the next campaign begins. All cleaning verification results are documented in the production batch record. Dedicated allergen-free campaigns require additional validated allergen-specific cleaning protocols and residue testing.

Q: How do you handle out-of-specification (OOS) batches?

A: OOS events trigger a structured investigation protocol: immediate batch hold pending root-cause analysis, review of in-process control data and environmental monitoring records, equipment and analyst qualification verification, and identification of corrective and preventive actions (CAPA). Batches failing safety-critical acceptance criteria (pathogen presence, excessive heavy metals) are rejected and destroyed. Batches with non-critical deviations may be reprocessed or released with documented justification depending on client agreement and regulatory requirements.

Q: How do you prevent cross-contamination between production campaigns?

A: Cross-contamination prevention is managed through: dedicated, segregated food-grade production suites; validated cleaning and sanitization protocols with documented effectiveness; pre- and post-campaign environmental monitoring (surface swabbing, air sampling, equipment rinse-water testing); single-strain campaigns with full suite sanitization between strains; and raw material segregation with dedicated storage. Cleaning verification results are included in the production batch record.

logo 24/7

We are here to help you further your
development in the microbiology field.

SUBSCRIBE

Enter your email here to subscribe

Copyright © Creative BioMart. All Rights Reserved.